Post by PressReleaseon Mar 05, 2024 8:11am
47 Views
Post# 35915255
New Press Release - FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum